May I take this opportunity to welcome you to the University of Hull’s Postgraduate Medical Institute (PGMI) web site. The Institute has been in existence for 17 years and over that period has become increasingly successful in both the fields of research and postgraduate teaching. There are currently 9 chairs in the Institute, whose total workforce is 141 people. We have been very fortunate in securing the long lasting support of the NHS and this, in turn, has meant that the majority of the Chairs in the Institute are clinically based.
Following an internal review the Institute has been restructured into three divisions; Cancer Studies, Cardiovascular/Respiratory Studies, Community/Rehabilitation Studies. This has resulted in a more efficient management and financial structure being put into place.
In a competitive academic environment the Institute has developed a targeted approach to its research programmes. These include research into specific cancers and cardiovascular diseases. The Institute has been very successful in these fields and has achieved an international reputation for its work in both. Over the last three years it has achieved a grant income in excess of £5 million and is currently the University’s top earning Faculty. We were the most successful department in the University of Hull as far as our submission in the 2008 RAE was concerned. Under UoA 12 (Allied Health Professions and Studies) we were rated 6th out of 68 units in the UK.
The £7.5 million Daisy Appeal development funded by charitable monies was opened on the Castle Hill Hospital campus in 2008 and provides new research and teaching facilities. Indeed, the majority of the University’s medical research now takes place in the building.
Through the second phase of the Daisy Appeal, PGMI is currently developing significant links with Chemistry with the intention of establishing a truly collaborative lab-to-bedside programme of molecular imaging research, based on PET-CT technologies.
With the Hull York Medical School now established with an annual intake of 130 students (the first cohort of whom graduated in 2008), the future of academic medicine, both teaching and research, remains secure in Hull and I am sure that we will continue to go from strength to strength. The opportunities here are considerable for anybody proposing either an undergraduate or postgraduate career in academic medicine.
Professor Nicholas D Stafford
Director
Postgraduate Medical Institute
Page last updated by wayne sheedy on 3/14/2011